MiCardia Corporation announced today the completion of a $9 million Series B Preferred financing.  This financing was led by HBM Biocapital, with additional shares sold to Japan Asia Investment Company, Ltd., the MedFocus Family of Funds, the BioStar Private Equity Fund, LLC and a number of private individuals.  The proceeds from this financing will be used to further develop the Company’s Dynamic Adjustable Cardiovascular Implant Technologies and initial human clinical trials for its’ initial products ...read more